Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin. (Q53151440)
Jump to navigation
Jump to search
scientific article published on 13 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin. |
scientific article published on 13 August 2012 |
Statements
Serum lactate dehydrogenase predicts for overall survival benefit in patients with metastatic renal cell carcinoma treated with inhibition of mammalian target of rapamycin (English)
Andrew J Armstrong
Daniel J George
13 August 2012